Details
Stereochemistry | RACEMIC |
Molecular Formula | C17H20N4O |
Molecular Weight | 296.3669 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(CN1C2=C(NC3=C(C=CC=N3)C1=O)C=CC=C2)N(C)C
InChI
InChIKey=YFLBETLXDPBWTD-UHFFFAOYSA-N
InChI=1S/C17H20N4O/c1-12(20(2)3)11-21-15-9-5-4-8-14(15)19-16-13(17(21)22)7-6-10-18-16/h4-10,12H,11H2,1-3H3,(H,18,19)
Molecular Formula | C17H20N4O |
Molecular Weight | 296.3669 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Effects of long-term treatment of rats with antidepressants on adrenergic-receptor sensitivity in cerebral cortex: Structure activity study. | 1983 |
|
Effects of JL13, a pyridobenzoxazepine with potential atypical antipsychotic activity, in animal models for schizophrenia. | 2001 Jul |
|
Recent advances in the solid-phase combinatorial synthetic strategies for the benzodiazepine based privileged structures. | 2006 Jan |
|
Method development for a pyridobenzodiazepine library with multiple diversification points. | 2008 Mar-Apr |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:37:11 GMT 2023
by
admin
on
Fri Dec 15 15:37:11 GMT 2023
|
Record UNII |
09B57945V9
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C265
Created by
admin on Fri Dec 15 15:37:11 GMT 2023 , Edited by admin on Fri Dec 15 15:37:11 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
2470
Created by
admin on Fri Dec 15 15:37:11 GMT 2023 , Edited by admin on Fri Dec 15 15:37:11 GMT 2023
|
PRIMARY | |||
|
09B57945V9
Created by
admin on Fri Dec 15 15:37:11 GMT 2023 , Edited by admin on Fri Dec 15 15:37:11 GMT 2023
|
PRIMARY | |||
|
112029
Created by
admin on Fri Dec 15 15:37:11 GMT 2023 , Edited by admin on Fri Dec 15 15:37:11 GMT 2023
|
PRIMARY | |||
|
C003256
Created by
admin on Fri Dec 15 15:37:11 GMT 2023 , Edited by admin on Fri Dec 15 15:37:11 GMT 2023
|
PRIMARY | |||
|
10321-12-7
Created by
admin on Fri Dec 15 15:37:11 GMT 2023 , Edited by admin on Fri Dec 15 15:37:11 GMT 2023
|
PRIMARY | |||
|
Propizepine
Created by
admin on Fri Dec 15 15:37:11 GMT 2023 , Edited by admin on Fri Dec 15 15:37:11 GMT 2023
|
PRIMARY | |||
|
C72833
Created by
admin on Fri Dec 15 15:37:11 GMT 2023 , Edited by admin on Fri Dec 15 15:37:11 GMT 2023
|
PRIMARY | |||
|
m9216
Created by
admin on Fri Dec 15 15:37:11 GMT 2023 , Edited by admin on Fri Dec 15 15:37:11 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB10115MIG
Created by
admin on Fri Dec 15 15:37:11 GMT 2023 , Edited by admin on Fri Dec 15 15:37:11 GMT 2023
|
PRIMARY | |||
|
100000081361
Created by
admin on Fri Dec 15 15:37:11 GMT 2023 , Edited by admin on Fri Dec 15 15:37:11 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104749
Created by
admin on Fri Dec 15 15:37:11 GMT 2023 , Edited by admin on Fri Dec 15 15:37:11 GMT 2023
|
PRIMARY | |||
|
2301
Created by
admin on Fri Dec 15 15:37:11 GMT 2023 , Edited by admin on Fri Dec 15 15:37:11 GMT 2023
|
PRIMARY | |||
|
DTXSID20864247
Created by
admin on Fri Dec 15 15:37:11 GMT 2023 , Edited by admin on Fri Dec 15 15:37:11 GMT 2023
|
PRIMARY | |||
|
233-705-9
Created by
admin on Fri Dec 15 15:37:11 GMT 2023 , Edited by admin on Fri Dec 15 15:37:11 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |